Novavax
NVAX
$4.09
Share price
3.54%
Change (1 day)
-46.68%
Change (1 year)
Categories
Number of shares outstanding for Novavax (NVAX)
Number of shares outstanding as of April 2024 : 103,429,000
According to Novavax's latest financial reports and stock price the company's current number of shares outstanding is 103,429,000. At the end of 2023 the company had 103,429,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Novavax from 2019 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 0.10 B | 29.57% |
| 2022 | 79.82 M | 5.49% |
| 2021 | 75.67 M | 15.13% |
| 2020 | 65.72 M | 134.21% |
| 2019 | 28.06 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | 2,044,000,000 | 1,876.23% | 🇨🇭 Switzerland |
 Pfizer PFE | 5,647,000,000 | 5,359.78% | 🇺🇸 USA |
 AstraZeneca AZN | 3,098,000,000 | 2,895.29% | 🇬🇧 UK |
 GlaxoSmithKline GSK | 2,028,000,000 | 1,860.77% | 🇬🇧 UK |
 Sarepta Therapeutics
SRPT | 88,889,000 | -14.06% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | 47,261,000 | -54.31% | 🇺🇸 USA |
 Agenus
AGEN | 378,152,000 | 265.62% | 🇺🇸 USA |
 NanoViricides NNVC | 11,745,906 | -88.64% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | 189,644,000 | 83.36% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | 51,800,000 | -49.92% | 🇺🇸 USA |